BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36969172)

  • 21. Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Bae SC; Lee YH
    Clin Rheumatol; 2018 May; 37(5):1199-1205. PubMed ID: 29392511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Meta-analysis of RCT studies on clinical efficacy of single administration of Tripterygium Glycosides Tablets or combined administration with methotrexate against rheumatoid arthritis].
    Chen WJ; Li TX; Wang XY; Xue ZP; Lyu C; Li HZ; Li YQ; Fan YF; Tian YG; Yang J; Guo MQ; Wang JX; Wu HY; Zhang YQ; Lin N
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(4):791-797. PubMed ID: 32237478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cream, prepared with Tripterygium wilfordii Hook F and other four medicinals, on joint pain and swelling in patients with rheumatoid arthritis: a double-blinded, randomized, placebo controlled clinical trial.
    Jiao J; Tang X; Gong X; Yin H; Jiang Q; Wei C
    J Tradit Chin Med; 2019 Feb; 39(1):89-96. PubMed ID: 32186028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.
    Goldbach-Mansky R; Wilson M; Fleischmann R; Olsen N; Silverfield J; Kempf P; Kivitz A; Sherrer Y; Pucino F; Csako G; Costello R; Pham TH; Snyder C; van der Heijde D; Tao X; Wesley R; Lipsky PE
    Ann Intern Med; 2009 Aug; 151(4):229-40, W49-51. PubMed ID: 19687490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis.
    Alfonso-Cristancho R; Armstrong N; Arjunji R; Riemsma R; Worthy G; Ganguly R; Kleijnen J
    Clin Rheumatol; 2017 Jan; 36(1):25-34. PubMed ID: 27726046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials.
    Zheng W; Mei Y; Chen C; Cai L; Chen H
    Phytother Res; 2021 Jun; 35(6):2902-2924. PubMed ID: 33368709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of tripterygium glycosides (TG) in rheumatoid arthritis as a disease-modifying anti-rheumatic drug (DMARD) in combination with conventional DMARDs: A systematic review and meta-analysis of randomized controlled trials.
    Feng Z; Fu L; Wang J; Zhu Y; He X; Zhou L; Zhou X
    Pharmacol Res; 2022 Oct; 184():106405. PubMed ID: 36028187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety of biosimilar-infliximab and originator-infliximab in combination with methotrexate in patients with active rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Bae SC; Lee YH
    Int J Rheum Dis; 2018 May; 21(5):922-929. PubMed ID: 29671942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials.
    Song GG; Choi SJ; Lee YH
    Int J Rheum Dis; 2019 Aug; 22(8):1563-1571. PubMed ID: 31211506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical symptoms effect of Tripterygium Glycosides Tablets alone or combined with methotrexate in treatment of rheumatoid arthritis: a Meta-analysis].
    Wang XY; Li TX; Xue ZP; Lyu C; Li HZ; Fan YF; Li YQ; Tian YG; Yang J; Chen WJ; Guo MQ; Wang JX; Wu HY; Zhang YQ; Lin N
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3533-3541. PubMed ID: 31602919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systematic reviews of effects of Tripterygium Glycosides Tablets on pro-inflammatory factors in rheumatoid arthritis].
    Yang J; Li TX; Wang XY; Xue ZP; Lyu C; Li HZ; Fan YF; Li YQ; Tian YG; Chen WJ; Guo MQ; Wang JX; Wu HY; Zhang YQ; Zhu CY; Lin N
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(4):764-774. PubMed ID: 32237476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and meta-analysis of rituximab combined with methotrexate versus methotrexate alone in the treatment of rheumatoid arthritis.
    Wang Z; Bao HW; Ji Y
    Medicine (Baltimore); 2020 Feb; 99(8):e19193. PubMed ID: 32080104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety and effectiveness of a chloroform/methanol extract of Tripterygium wilfordii Hook F (T2) plus methotrexate in treating rheumatoid arthritis.
    Zhang W; Shi Q; Zhao LD; Li Y; Tang FL; Zhang FC; Zhang X
    J Clin Rheumatol; 2010 Dec; 16(8):375-8. PubMed ID: 21085018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety.
    Bao J; Dai SM
    Rheumatol Int; 2011 Sep; 31(9):1123-9. PubMed ID: 21365177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Z Rheumatol; 2020 Aug; 79(6):590-603. PubMed ID: 31781849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
    Emery P; Fleischmann RM; Moreland LW; Hsia EC; Strusberg I; Durez P; Nash P; Amante EJ; Churchill M; Park W; Pons-Estel BA; Doyle MK; Visvanathan S; Xu W; Rahman MU
    Arthritis Rheum; 2009 Aug; 60(8):2272-83. PubMed ID: 19644849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects and safety of Sinomenine in treatment of rheumatoid arthritis contrast to methotrexate: a systematic review and Meta-analysis.
    Liu W; Qian X; Ji W; Lu Y; Wei G; Wang Y
    J Tradit Chin Med; 2016 Oct; 36(5):564-77. PubMed ID: 29932627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis.
    Li Y; Zhu W; He H; Garov YA; Bai L; Zhang L; Wang J; Wang J; Zhou X
    Front Pharmacol; 2021; 12():691031. PubMed ID: 34177599
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial.
    Xu J; Zhang L; Xu Y; Yu J; Zhao L; Deng H; Li M; Zhang M; Lei X; Hu C; Jiao W; Dai Z; Liu L; Chen G
    Phytomedicine; 2023 Apr; 112():154704. PubMed ID: 36796186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.